BioAtla, Inc.

Listed Company
BCABCIK 0001826892NasdaqNon-AcceleratedSmaller ReportingBiological Products, (No Diagnostic Substances)DelawareFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
—
Total Assets
—
Equity
—
Shares Out
1.66M
Op. Cash Flow
$-48.20M
BCAB$3.91−73.53% · past yearDBEQ Basic
Daily closing prices

Business

BioAtla is a clinical-stage biopharmaceutical company developing conditionally active biologics (CABs), a novel class of pH-dependent antibody therapeutics designed to selectively bind tumor antigens in the acidic tumor microenvironment while remaining inactive in normal tissue. The company's pipeline includes clinical-stage candidates for solid tumors and preclinical assets. BioAtla operates primarily in the United States and has entered collaborations with strategic partners including Bristol-Myers Squibb, BeOne Medicines, Himalaya Therapeutics, Context Therapeutics, and Inversagen AI.

Summary from 10-K filed 2026-03-31

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue—
Net income—
Total assets—
Total liabilities—
Stockholders' equity—
Operating cash flow$-48.20M

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is BioAtla, Inc.'s CIK number?

BioAtla, Inc.'s SEC CIK number is 0001826892 (1826892). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find BioAtla, Inc.'s SEC filings?

All of BioAtla, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did BioAtla, Inc. last report earnings?

BioAtla, Inc. (BCAB) most recently filed an earnings 8-K with the SEC on Mar 31, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-134501). This is BioAtla, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is BioAtla, Inc.'s most recent earnings 8-K?

BioAtla, Inc.'s latest earnings 8-K (Item 2.02) was filed Mar 31, 2026 under accession 0001193125-26-134501. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View BioAtla, Inc.'s latest earnings 8-K →
Look up any company's CIK number →